Growth Metrics

Insmed (INSM) Income towards Parent Company (2016 - 2026)

Insmed's Income towards Parent Company history spans 17 years, with the latest figure at -$163.6 million for Q1 2026.

  • Quarterly Income towards Parent Company rose 36.25% to -$163.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$1.2 billion through Mar 2026, down 16.82% year-over-year, with the annual reading at -$1.3 billion for FY2025, 39.73% down from the prior year.
  • Income towards Parent Company came in at -$163.6 million for Q1 2026, up from -$328.5 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of -$94.6 million in Q1 2022 to a low of -$370.0 million in Q3 2025.
  • The 5-year median for Income towards Parent Company is -$186.1 million (2023), against an average of -$210.9 million.
  • Year-over-year, Income towards Parent Company plummeted 155.96% in 2023 and then soared 36.25% in 2026.
  • Insmed's Income towards Parent Company stood at -$160.1 million in 2022, then fell by 16.23% to -$186.1 million in 2023, then decreased by 26.61% to -$235.6 million in 2024, then plummeted by 39.44% to -$328.5 million in 2025, then skyrocketed by 50.21% to -$163.6 million in 2026.
  • Per Business Quant, the three most recent readings for INSM's Income towards Parent Company are -$163.6 million (Q1 2026), -$328.5 million (Q4 2025), and -$370.0 million (Q3 2025).